Your browser doesn't support javascript.
loading
An Exploration of the Role of Osteoclast Lineage Cells in Bone Tissue Engineering.
Devoy, Eoin J; Jabari, Erfan; Kotsanos, George; Choe, Robert H; Fisher, John P.
Afiliação
  • Devoy EJ; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Jabari E; Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
  • Kotsanos G; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Choe RH; Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
  • Fisher JP; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Article em En | MEDLINE | ID: mdl-39041616
ABSTRACT
Bone defects because of age, trauma, and surgery, which are exacerbated by medication side effects and common diseases such as osteoporosis, diabetes, and rheumatoid arthritis, are a problem of epidemic scale. The present clinical standard for treating these defects includes autografts and allografts. Although both treatments can promote robust regenerative outcomes, they fail to strike a desirable balance of availability, side effect profile, consistent regenerative efficacy, and affordability. This difficulty has contributed to the rise of bone tissue engineering (BTE) as a potential avenue through which enhanced bone regeneration could be delivered. BTE is founded upon a paradigm of using biomaterials, bioactive factors, osteoblast lineage cells (ObLCs), and vascularization to cue deficient bone tissue into a state of regeneration. Despite promising preclinical results, BTE has had modest success in being translated into the clinical setting. One barrier has been the simplicity of its paradigm relative to the complexity of biological bone. Therefore, this paradigm must be critically examined and expanded to better account for this complexity. One potential avenue for this is a more detailed consideration of osteoclast lineage cells (OcLCs). Although these cells ostensibly oppose ObLCs and bone regeneration through their resorptive functions, a myriad of investigations have shed light on their potential to influence bone equilibrium in more complex ways through their interactions with both ObLCs and bone matrix. Most BTE research has not systematically evaluated their influence. Yet contrary to expectations associated with the paradigm, a selection of BTE investigations has demonstrated that this influence can enhance bone regeneration in certain contexts. In addition, much work has elucidated the role of many controllable scaffold parameters in both inhibiting and stimulating the activity of OcLCs in parallel to bone regeneration. Therefore, this review aims to detail and explore the implications of OcLCs in BTE and how they can be leveraged to improve upon the existing BTE paradigm.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Tissue Eng Part B Rev Assunto da revista: BIOTECNOLOGIA / HISTOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Tissue Eng Part B Rev Assunto da revista: BIOTECNOLOGIA / HISTOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos